We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXPE icon
451
Expedia Group
EXPE
$36.5B
$2.64M 0.02%
+17,848
New +$2.36M
NOMD icon
452
Nomad Foods
NOMD
$1.77B
$2.64M 0.02%
138,366
-7,053
-5% -$130K
HES
453
DELISTED
Hess
HES
$2.63M 0.02%
19,355
+930
+5% +$129K
NTRS icon
454
Northern Trust
NTRS
$21.8B
$2.62M 0.02%
29,102
+4,424
+18% +$387K
TROW icon
455
T. Rowe Price
TROW
$25.5B
$2.58M 0.01%
23,666
+1,781
+8% +$196K
VTR icon
456
Ventas
VTR
$47.5B
$2.58M 0.01%
40,161
-2,125
-5% -$124K
SBAC icon
457
SBA Communications
SBAC
$19.8B
$2.55M 0.01%
10,602
-397
-4% -$88K
NUE icon
458
Nucor
NUE
$58.3B
$2.52M 0.01%
16,780
-110
-0.7% -$16.5K
LH icon
459
Labcorp
LH
$25.2B
$2.52M 0.01%
11,268
-45,015
-80% -$9.89M
ARE icon
460
Alexandria Real Estate Equities
ARE
$9.37B
$2.52M 0.01%
21,197
+1,564
+8% +$186K
MAS icon
461
Masco
MAS
$14.3B
$2.5M 0.01%
29,787
-1,925
-6% -$146K
WY icon
462
Weyerhaeuser
WY
$17.6B
$2.5M 0.01%
73,800
+1,492
+2% +$45.8K
MLM icon
463
Martin Marietta Materials
MLM
$34.2B
$2.49M 0.01%
4,627
-152
-3% -$82.2K
RMD icon
464
ResMed
RMD
$31.1B
$2.47M 0.01%
10,103
+732
+8% +$164K
KVUE icon
465
Kenvue
KVUE
$38B
$2.44M 0.01%
105,564
+19,686
+23% +$408K
ARKF icon
466
ARK Blockchain & Fintech Innovation ETF
ARKF
$731M
$2.4M 0.01%
80,552
– –
EXR icon
467
Extra Space Storage
EXR
$32.3B
$2.39M 0.01%
13,279
+1,336
+11% +$225K
CAH icon
468
Cardinal Health
CAH
$53.7B
$2.33M 0.01%
21,045
-110,540
-84% -$11.6M
NLY icon
469
Annaly Capital Management
NLY
$17.3B
$2.31M 0.01%
115,325
+8,009
+7% +$160K
IFF icon
470
International Flavors & Fragrances
IFF
$20.3B
$2.29M 0.01%
21,803
+191
+0.9% +$19K
HSY icon
471
Hershey
HSY
$37.3B
$2.26M 0.01%
11,803
+331
+3% +$64.3K
WAT icon
472
Waters Corp
WAT
$37.3B
$2.26M 0.01%
6,267
+495
+9% +$161K
CFG icon
473
Citizens Financial Group
CFG
$30.1B
$2.25M 0.01%
54,848
+3,459
+7% +$140K
HRI icon
474
Herc Holdings
HRI
$4.78B
$2.25M 0.01%
14,114
-20,070
-59% -$2.84M
XYZ
475
Block Inc
XYZ
$48.9B
$2.24M 0.01%
33,438
+4,541
+16% +$293K
17 18
19
20 21

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.